Amazon's RxPass Will Help It Tap Into the Pharmaceutical Market as It Seeks to Grow Revenue Beyond 500 Billion

Amazon is adding generic medications to the list of goods and services it offers. How will that impact its revenue and share price?. – StockNews

Amazon may suffer due to the economic contraction occurring, but its expansion into the pharmaceutical market may help offset some of these losses. That is thinking behind RxPass, Amazon’s latest offering that allows its Prime members to order generic medications for a $5 USD per month subscription fee. Below, we take a look at some of Amazon’s recent financials and price momentum.

Tracking AMZN’s Performance from 2020 to 2022: Net Income, Price/Sales Ratio, and Revenue

AMZN‘s net income has been

→ Continue reading at Entrepreneur

More from author

Related posts


Latest posts

One nation, under Swift | CNN Business

Editor’s Note: A version of this story appeared in CNN Business’ Nightcap newsletter. To get it in your inbox, sign up for free,...

The Woman Photographed In a Sleeping Bag at Twitter HQ Is Now One of the Company's Most 'Influential Leaders.'

At Twitter, putting in long hours apparently pays off big time.Just ask Esther Crawford, Twitter's director of product management.In November, Crawford shared a photo...

Tesla invests $3.6 billion to expand Nevada complex with two factories | CNN Business

Tesla said on Tuesday it would invest more than $3.6 billion to expand its Nevada manufacturing complex with two new factories, including the...